A-kinase interacting protein 1, a potential biomarker associated with advanced tumor features and CXCL1/2 in prostate cancer.

Wang, Danlan; Luo, Yuanfang; Guo, Yonglian; Li, Guohao; Li, Fan

Wang, Danlan; Luo, Yuanfang; Guo, Yonglian; Li, Guohao; Li, Fan.

Afiliação

Wang D; Department of Urology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.
Luo Y; Department of Urology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.
Guo Y; Department of Urology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.
Li G; Department of Urology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.
Li F; Department of Urology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.

Int J Biol Markers ; 35(2): 74-81, 2020 Jun.

Article em En | MEDLINE | ID: mdl-32339056

Assuntos

Quimiocina CXCL1/metabolismo; Proteínas Nucleares/metabolismo; Neoplasias da Próstata/genética; Biomarcadores Tumorais; Linhagem Celular Tumoral; Humanos; Masculino; Pessoa de Meia-Idade; Prognóstico

Palavras-chave

AKIP1; CXCL1; CXCL2; Prostate cancer; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Proteínas Nucleares / Quimiocina CXCL1 Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google